Cord Blood Units with Low CD34+ Cell Viability Have a Low Probability of Engraftment after Double Unit Transplantation  Andromachi Scaradavou, Katherine.

Slides:



Advertisements
Similar presentations
Circulating Endothelial Progenitor Cells Decreased in Patients with Sclerodermatous Chronic Graft-versus-Host Disease  Kazuho Shimura, Eishi Ashihara,
Advertisements

Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T-Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%  Pooja.
Alternative Allogeneic Donor Sources for Transplantation for Childhood Diseases: Unrelated Cord Blood and Haploidentical Family Donors  Mitchell S. Cairo,
IV Busulfan Dose Individualization in Children undergoing Hematopoietic Stem Cell Transplant: Limited Sampling Strategies  L. Lee Dupuis, Cathryn Sibbald,
High-Content Flow Cytometry and Temporal Data Analysis for Defining a Cellular Signature of Graft-Versus-Host Disease  Ryan Remy Brinkman, Maura Gasparetto,
In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial  Divya T. Koura, John T.
Content of Endothelial Progenitor Cells in Autologous Stem Cell Grafts Predict Survival after Transplantation for Multiple Myeloma  Egil S. Blix, Anders.
Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment after Unrelated Umbilical Cord Blood Transplantation:
David Myerson, Gideon Steinbach, Ted A. Gooley, Howard M. Shulman 
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
Content of Endothelial Progenitor Cells in Autologous Stem Cell Grafts Predict Survival after Transplantation for Multiple Myeloma  Egil S. Blix, Anders.
Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host.
A Novel Reduced-Intensity Conditioning Regimen Induces a High Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment after Double-Unit.
Peripheral Blood CD34+ Cell Enumeration as a Predictor of Apheresis Yield: An Analysis of More Than 1,000 Collections  Peter Gambell, Kirsten Herbert,
Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic.
Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-
Noninherited Maternal Antigens Identify Acceptable HLA Mismatches: Benefit to Patients and Cost-Effectiveness for Cord Blood Banks  Henk G.M. Van der.
HLA-Haploidentical T Cell–Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Children with Fanconi Anemia  Marco Zecca, Luisa Strocchio, Daria.
Cotransplantation of Ex Vivo Expanded and Unexpanded Cord Blood Units in Immunodeficient Mice Using Insulin Growth Factor Binding Protein-2–Augmented.
Sabina Kersting, Leo F. Verdonck 
Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection.
Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte Globulin  Craig Sauter, Michelle Abboud,
Frequent Human Herpesvirus-6 Viremia But Low Incidence of Encephalitis in Double- Unit Cord Blood Recipients Transplanted Without Antithymocyte Globulin 
Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?  Jason W. Chien, Keith M. Sullivan  Biology.
Optimizing Unrelated Donor Cord Blood Transplantation
A Comparison of the Kinetics of Nucleated Cells and CD34+ Cells in Neonatal Peripheral Blood and Cord Blood  Joong-Pyo Kim, Young-Ho Lee, Young-Ah Lee,
Caroline F. Morrison, Donna M
B7 Costimulation and Intracellular Indoleamine 2,3-Dioxygenase Expression in Umbilical Cord Blood and Adult Peripheral Blood  Enikő Grozdics, László Berta,
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord.
Bone Marrow–Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality  Elizabeth O. Stenger, Raghavan Chinnadurai,
Cytomegalovirus Infection after Allogeneic Transplantation: Comparison of Cord Blood with Peripheral Blood and Marrow Graft Sources  Christopher M. Walker,
Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation  Jessica T. Stover,
A “No-wash” Albumin-Dextran Dilution Strategy for Cord Blood Unit Thaw: High Rate of Engraftment and a Low Incidence of Serious Infusion Reactions  Juliet.
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies  Gunjan L. Shah, Leyla Shune,
“No Wash” Albumin-Dextran Dilution for Double-Unit Cord Blood Transplantation is Safe with High Rates of Sustained Donor Engraftment  Parastoo B. Dahi,
Late-Onset Colitis after Cord Blood Transplantation Is Consistent with Graft-Versus-Host Disease: Results of a Blinded Histopathological Review  Filippo.
Atul Sathe, Sterling B. Ortega, Dorothy I. Mundy, Robert H
Availability of Cord Blood Extends Allogeneic Hematopoietic Stem Cell Transplant Access to Racial and Ethnic Minorities  Juliet N. Barker, Courtney E.
Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation  Mats Remberger, Johan Törlén, Olle.
Higher CD34+ and CD3+ Cell Doses in the Graft Promote Long-Term Survival, and Have No Impact on the Incidence of Severe Acute or Chronic Graft-versus-Host.
Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation Has Unique Features and an Association with Engrafting Unit-to-Recipient HLA Match 
Evaluation of Initial Telomere Length and Changes after Transplantation in Adult Double-Unit Cord Blood Transplant Recipients  Beth Ashbridge, Ahmet Zehir,
Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses  Seitaro Terakura, Eiichi.
Efficacy of CD34+ Stem Cell Dose in Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation after Total Body Irradiation  Anurag K.
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating.
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
HLA-Mismatched, Noninherited Maternal Antigen–Matched Unrelated Cord Blood Transplantations Have Superior Survival: How HLA Typing the Cord Blood Donor's.
Post-Thaw Viable CD45+ Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in.
Gerard Socié, K. Scott Baker, Smita Bhatia 
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation  Mohammed M. Elayan, Justin G.
What is quality in a transplant program?
Richard Mitchell, John E. Wagner, Claudio Brunstein, Qing Cao, David H
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Unrelated Stem Cell Transplantation after a Reduced Intensity Conditioning Regimen Containing High-Dose Thymoglobulin Leads to Controllable Graft-versus-Host.
Blood and Marrow Transplant Handbook
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Varicella-Zoster Virus Disease Is More Frequent after Cord Blood Than after Bone Marrow Transplantation  Kristel Vandenbosch, Philippe Ovetchkine, Martin.
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350 cGy) and Fludarabine Conditioning  Junya Kanda, David.
Real Time Immunophenotyping of Leukocyte Subsets Early after Double Cord Blood Transplantation Predicts Graft Function  Jianqiang Li, Ian Nicoud, Joseph.
CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking by Juliet N. Barker, Jane Kempenich, Joanne.
Analysis of 402 Cord Blood Units to Assess Factors Influencing Infused Viable CD34+ Cell Dose: The Critical Determinant of Engraftment  Duncan Purtill,
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation  Eric Davis, Sean Devlin, Candice Cooper,
Mary Eapen  Biology of Blood and Marrow Transplantation 
Correlation of Infused CD3+CD8+ Cells with Single-Donor Dominance after Double-Unit Cord Blood Transplantation  Filippo Milano, Shelly Heimfeld, Ted Gooley,
Optimal Donor Selection: Beyond HLA
Graft Monocytic Myeloid-Derived Suppressor Cell Content Predicts the Risk of Acute Graft-versus-Host Disease after Allogeneic Transplantation of Granulocyte.
Quality Analysis of Cord Blood Unit (CBU) Segments at the Bank Correlates with the Post-Thaw Transplant Center Results after Albumin-Dextran Dilution 
Reduced Late Mortality Risk Contributes to Similar Survival after Double-Unit Cord Blood Transplantation Compared with Related and Unrelated Donor Hematopoietic.
Presentation transcript:

Cord Blood Units with Low CD34+ Cell Viability Have a Low Probability of Engraftment after Double Unit Transplantation  Andromachi Scaradavou, Katherine M. Smith, Rebecca Hawke, Allison Schaible, Michelle Abboud, Nancy A. Kernan, James W. Young, Juliet N. Barker  Biology of Blood and Marrow Transplantation  Volume 16, Issue 4, Pages 500-508 (April 2010) DOI: 10.1016/j.bbmt.2009.11.013 Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Flow cytometric evaluation of CB units postthaw. Live cells are shown in green, dead cells are shown in red, and debris is shown in black. (A) Modified gating strategy. Plot 1: the lower FSC primary threshold excludes most debris but no dead cells. Plot 2: viability is assessed in the FSC versus 7AAD dot plot. Debris is shown in R6 and is gated out in all subsequent plots. Dead cells (7AAD-positive) are in R7 whereas live cells (7AAD-negative) are in R5. Plot 3: for comparison traditional gating cannot adequately distinguish debris from viable cells in the 7AAD versus SSC dot plot. Live and dead cells are shown for CD45+ (Plot 4), CD34+ (Plot 5), and CD3+ (Plot 6) cell populations. Viability was calculated from the total debris-free sample for CD45+ cells (Plot 7), CD34+ cells (Plot 8), and CD3+ cells (Plot 9). An average of 300 events (range: 100-1000) were acquired per sample for the CD34+ cell analysis. (B) Traditional gating strategy. The same plots as in A are shown with a high FSC threshold that excludes most dead cells, as frequently used in traditional gating. In CB units with a high percentage of dead cells the traditional methodology overestimates cell viability compared with our modified gating. (C) Comparison of CD34+ cell viability using modified and traditional gating in CB units with a small percentage of dead cells. The difference between the 2 gating strategies is small. Biology of Blood and Marrow Transplantation 2010 16, 500-508DOI: (10.1016/j.bbmt.2009.11.013) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Flow cytometric evaluation of CB units postthaw. Live cells are shown in green, dead cells are shown in red, and debris is shown in black. (A) Modified gating strategy. Plot 1: the lower FSC primary threshold excludes most debris but no dead cells. Plot 2: viability is assessed in the FSC versus 7AAD dot plot. Debris is shown in R6 and is gated out in all subsequent plots. Dead cells (7AAD-positive) are in R7 whereas live cells (7AAD-negative) are in R5. Plot 3: for comparison traditional gating cannot adequately distinguish debris from viable cells in the 7AAD versus SSC dot plot. Live and dead cells are shown for CD45+ (Plot 4), CD34+ (Plot 5), and CD3+ (Plot 6) cell populations. Viability was calculated from the total debris-free sample for CD45+ cells (Plot 7), CD34+ cells (Plot 8), and CD3+ cells (Plot 9). An average of 300 events (range: 100-1000) were acquired per sample for the CD34+ cell analysis. (B) Traditional gating strategy. The same plots as in A are shown with a high FSC threshold that excludes most dead cells, as frequently used in traditional gating. In CB units with a high percentage of dead cells the traditional methodology overestimates cell viability compared with our modified gating. (C) Comparison of CD34+ cell viability using modified and traditional gating in CB units with a small percentage of dead cells. The difference between the 2 gating strategies is small. Biology of Blood and Marrow Transplantation 2010 16, 500-508DOI: (10.1016/j.bbmt.2009.11.013) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Postthaw CD34+, CD3+, and CD45+ cell viability and unit engraftment in 44 double unit CB grafts. The distribution of postthaw viabilities of the CD34+, CD3+, and CD45+ cells are shown for the engrafting (in closed symbols) and nonengrafting units (open symbols) for the 44 patients with single unit engraftment. Biology of Blood and Marrow Transplantation 2010 16, 500-508DOI: (10.1016/j.bbmt.2009.11.013) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Postthaw CD34+ cell viability and CB bank of origin (N=92 units). CB units were obtained from domestic (N=71), and international banks (INT, N=21). Each group depicts the distribution of viability for the respective units from each bank (for the domestic) or each country (for the international ones). Biology of Blood and Marrow Transplantation 2010 16, 500-508DOI: (10.1016/j.bbmt.2009.11.013) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Schema depicting the difference between the dose of viable CD34+ cells/kg versus the percentage of viable CD34+ cells in 2 CB units. The infused viable CD34+ cells per kg of the recipient weight (CD34+ cell dose) and the percent CD34+ cell viability (7AAD-positive CD34+ cells divided by the total CD34+ cells in the unit expressed as a percentage) represent 2 different graft characteristics. In this example the 2 CB units have the same total number of viable CD34+ cells (and would have an identical infused CD34+ cell dose). However, the percentage of viable CD34+ cells is markedly different. Based on the results of this study unit, #1 is of poor quality and we would predict that unit #2 would engraft in the double unit setting. Biology of Blood and Marrow Transplantation 2010 16, 500-508DOI: (10.1016/j.bbmt.2009.11.013) Copyright © 2010 American Society for Blood and Marrow Transplantation Terms and Conditions